<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">335568</id>
  <title nil="true"/>
  <common-name>N-[(e)-[4-[bis(2-chloroethyl)amino]phenyl]methylideneamino]-2-[4-(4-methoxy-3-nitrophenyl)imidazol-1-yl]acetamide</common-name>
  <description>N-[(e)-[4-[bis(2-chloroethyl)amino]phenyl]methylideneamino]-2-[4-(4-methoxy-3-nitrophenyl)imidazol-1-yl]acetamide is a chemical compound with the formula C23H24Cl2N6O4. With an average molecular weight of 519.40 g/mol, N-[(e)-[4-[bis(2-chloroethyl)amino]phenyl]methylideneamino]-2-[4-(4-methoxy-3-nitrophenyl)imidazol-1-yl]acetamide is a heavy molecule.</description>
  <cas>93637-66-2</cas>
  <pubchem-id>44144874</pubchem-id>
  <chemical-formula>C23H24Cl2N6O4</chemical-formula>
  <weight>519.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T17:45:54Z</created-at>
  <updated-at type="dateTime">2026-08-30T17:45:54Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=C(C=C(C=C1)C2=CN(C=N2)CC(=O)NN=CC3=CC=C(C=C3)N(CCCl)CCCl)[N+](=O)[O-]</moldb-smiles>
  <moldb-formula>C23H24Cl2N6O4</moldb-formula>
  <moldb-inchi>InChI=1S/C23H24Cl2N6O4/c1-35-22-7-4-18(12-21(22)31(33)34)20-14-29(16-26-20)15-23(32)28-27-13-17-2-5-19(6-3-17)30(10-8-24)11-9-25/h2-7,12-14,16H,8-11,15H2,1H3,(H,28,32)/b27-13+</moldb-inchi>
  <moldb-inchikey>CLUFGPDFSBYRPV-UVHMKAGCSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">518.1236087</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM331461</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-[(e)-[4-[bis(2-chloroethyl)amino]phenyl]methylideneamino]-2-[4-(4-methoxy-3-nitrophenyl)imidazol-1-yl]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Imidazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0286039</sync-id>
  <structure-inchikey>CLUFGPDFSBYRPV-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000400000000080020000000000000000000000000001000000000040040200000000040200000000200000200000000000000000000080000000000000000000000000000000002000000000002000000000030000180400000040000000000003000000024000008010c000800000080900000080000800000000000800008040000400008024000000000080800000021000000000000000000000000000008000000000000004080000000000000001088000000000000020000080000000000000000000000000000000000011000000000000400200000000000000000000000080001048000000000400000001001020000000000000004000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJQAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:37:15Z</structure-indexed-at>
</compound>
